Organogenesis Holdings (ORGO)

• Market cap: $435M
• 1 day: 3.14%
• 5 days: -2.09%
• 1 month: -17.17%
• 3 months: 16.31%
• 6 months: 27.13%
• Year to date: -19.61%
• 1 year: -17.38%
• 5 years: -34.00%
• 10 years: -66.36%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

Employees: 862

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

3% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 40

3% less funds holding

Funds holding: 115 [Q2] → 111 (-4) [Q3]

8.27% less ownership

Funds ownership: 56.17% [Q2] → 47.9% (-8.27%) [Q3]

13% less capital invested

Capital invested by funds: $209M [Q2] → $182M (-$26.9M) [Q3]

22% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 18

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $66K